1. Home
  2. CUE vs III Comparison

CUE vs III Comparison

Compare CUE & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$36.51

Market Cap

233.5M

Sector

Health Care

ML Signal

HOLD

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$5.18

Market Cap

197.1M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUE
III
Founded
2014
2006
Country
United States
United States
Employees
N/A
1500
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
233.5M
197.1M
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
CUE
III
Price
$36.51
$5.18
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$120.00
$5.50
AVG Volume (30 Days)
140.7K
157.4K
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
4.46%
EPS Growth
61.11
216.67
EPS
N/A
0.12
Revenue
$27,466,000.00
$192,745,000.00
Revenue This Year
N/A
$3.85
Revenue Next Year
N/A
$4.34
P/E Ratio
N/A
$44.00
Revenue Growth
195.75
4.51
52 Week Low
$0.17
$3.74
52 Week High
$45.50
$6.45

Technical Indicators

Market Signals
Indicator
CUE
III
Relative Strength Index (RSI) 69.70 63.70
Support Level $24.35 $3.86
Resistance Level $41.42 $5.36
Average True Range (ATR) 3.24 0.14
MACD 1.23 -0.01
Stochastic Oscillator 86.62 68.09

Price Performance

Historical Comparison
CUE
III

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

Share on Social Networks: